Fig. 2.   Incidence of symptomatic ulcers, perforations, bleeds, and obstructions after 24 weeks' treatment with celecoxib 400 mg twice daily, diclofenac 75 mg twice daily (D) or ibuprofen 800 mg thrice daily (I). Trial stratified into two parts as designed